Vaginal micronized progesterone

DRUG4 trials

Conditions

Assisted Reproductive TreatmentsEarly Onset of Delivery Before 37 WeeksEndometrial Hyperplasia Without AtypiaHormonal ResponseOocyte MaturationOvarian FunctionOvulationPregnancy Loss

Phase 3

Efficacy of Progesterone and Low Molecular Weight Heparin in Recurrent Miscarriages

Not yet recruitingNCT07796737

General University Hospital, PraguePregnancy Loss, Pregnancy Loss, Early

Start: 2026-12-01End: 2030-12-31Target: 264Updated: 2026-09-09

Phase 4

Prevention of Preterm Birth in Pregnant Women at Risk Identified by Ultrasound: Evaluation of Two Treatment Strategies

CompletedNCT01643980

Dra.Cristina Martinez PayoEarly Onset of Delivery Before 37 Weeks

Start: 2012-08-31End: 2016-04-30Updated: 2016-10-17

Exogenous Progesterone as Ovulation Trigger

Not yet recruitingNCT07466199

Instituto Valenciano de Infertilidade de LisboaOvulation, Ovarian Function, Assisted Reproductive Treatments +2

Start: 2026-07-01End: 2026-08-01Target: 10Updated: 2026-06-04

Unknown Phase

Vaginal Micronized Progesterone Versus Levonorgestrel for Treatment of Non-atypical Endometrial Hyperplasia

CompletedNCT03992937

Kocaeli UniversityEndometrial Hyperplasia Without Atypia

Start: 2019-06-20End: 2020-12-01Updated: 2020-12-02

International Journal of Gynecology & Obstetrics2022-12-174 citations

Cervical Pessary Compared With Vaginal Progesterone for Preventing Early Preterm Birth

Obstetrics and Gynecology2018-09-2646 citations

Evaluation of two treatment strategies for the prevention of preterm birth in women identified as at risk by ultrasound (PESAPRO Trial): study protocol for a randomized controlled trial

Trials2015-09-2510 citations

Vaginal micronized progesterone

Sponsors

Conditions

Phase 3

Phase 4

Unknown Phase

Related Papers